Login
Companies $VTRS
$20.80 +$0.06 (0.29%) After hours
Viatris Inc logo

Viatris Inc

viatris.com

What Do They Do?

Sells branded medicines and generic drugs, including complex drugs, to pharmacies, wholesalers and healthcare institutions.

How Do They Make Money?

Customers buy Viatris medicines, and a sale counts when the products pass to them. It also receives license payments and sales-based royalties when licensees sell products or use licensed technology.

revenue
SegmentShareRevenue
Brands
Sold outright

64%
FY2022: 61%
Generics
Sold outright

36%
FY2022: 39%

Who Are Their Customers?

Viatris sells to wholesalers and distributors; pharmacies, pharmacy chains and care institutions may buy through wholesalers at separately arranged prices. Governments, insurers and other payers are also customers.

Do Revenues Turn Into Profits?

Not on paper. It lost $3.5B in FY2025, but brought in more cash than it spent: $1.9B of free cash flow.

Operating income, FY2025
−19% of revenue
▼ Turned to a loss vs FY2024 ($10.1M, 0%)
Net income, FY2025
−25% of revenue
▼ −454% (Loss) vs FY2024 (−$634.2M, −4%)
Free cash flow, FY2025
14% of revenue
▼ −2% vs FY2024 ($2B, 13%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ 0%
vs $3.8B in Q3 FY2025
Brands share of revenue vs 65.0% in Q3 FY2025
  • Aug 6, 2026 Viatris raised the midpoints of its 2026 financial guidance The company raised the midpoints for all metrics in its 2026 financial guidance.
  • May 4, 2026 CFO Doretta Mistras departed; Paul Campbell became interim CFO Mistras left for another professional opportunity, and the company named Campbell interim CFO.

Shrinking. Revenue fell 20% in 4 years, from $17.9B in FY2021 to $14.3B in FY2025, about 5% a year.

Portfolio divestitures Viatris has moved OTC, India API and women's healthcare businesses out of its portfolio: the older report listed planned divestitures, while the latest report describes completed divestitures.

Revenue over time
Brands Generics Net sales
$20B$10B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support